$34.50

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. Please allow 4-6 weeks for production.
Sku CI01578_5_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Na,e-Bis-Fmoc-L-lysine
Brand Name
Chem Impex
Product Number
01578
CAS
78081-87-5
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
13783708
IUPAC Name
(2S)-2,6-bis(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid
InChI Key
BMJRTKDVFXYEFS-XIFFEERXSA-N
SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCCCC@@H(C(=O)O)NC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46

Application

Na,e-Bis-Fmoc-L-lysine is widely utilized in research focused on:

Peptide Synthesis: This compound serves as a key building block in the synthesis of peptides, allowing researchers to create complex structures for various applications in drug development and biotechnology.

Protein Engineering: It is used in the modification of proteins to enhance their stability and functionality, which is crucial for developing therapeutic proteins and enzymes.

Drug Delivery Systems: The compound's unique properties make it suitable for formulating drug delivery systems, improving the bioavailability and targeting of therapeutic agents.

Bioconjugation: Na,e-Bis-Fmoc-L-lysine is employed in bioconjugation processes, facilitating the attachment of biomolecules to surfaces or other molecules, which is essential in diagnostics and targeted therapies.

Research in Cancer Therapeutics: Its application in the development of novel cancer treatments showcases its potential in creating targeted therapies that can improve patient outcomes.

References

Low-Loaded Polyethylene Glycol (PEG) Resin for High-Purity Peptide Synthesis and Cell Binding Assays

Publication Name: BioChip Journal
Publication Date: 2023-09-19
DOI: 10.1007/s13206-023-00120-4

A Tumor Homing Peptide-Conjugated Poly(epsilon-lysine) Delivery System for Improved Antitumor Drug Loading and Targeting

Publication Name: International Journal of Peptide Research and Therapeutics
Publication Date: 2023-05-16
DOI: 10.1007/s10989-023-10522-5

A tailored tetravalent peptide displays dual functions to inhibit amyloid β production and aggregation

Publication Name: Communications Biology
Publication Date: 2023-04-08
DOI: 10.1038/s42003-023-04771-9

Novel multivalent S100A8 inhibitory peptides attenuate tumor progression and metastasis by inhibiting the TLR4-dependent pathway

Publication Name: Cancer Gene Therapy
Publication Date: 2023-03-17
DOI: 10.1038/s41417-023-00604-3

Design and Synthesis of Peptides from Phoneutria nigriventer δ-Ctenitoxin-Pn2a for Antivenom Production

Publication Name: International Journal of Peptide Research and Therapeutics
Publication Date: 2023-02-18
DOI: 10.1007/s10989-023-10491-9